Everything You Need to Know About Insulin types for Step 1

Insulin questions are USMLE catnip: they’re fast, pattern-based, and loaded with high-yield traps (timing, onset/peak/duration, and which ones you can mix). If you can “see” an insulin curve in your head and match it to the patient’s story, you’ll pick up easy points on Step 1 and Step 2—especially on diabetes treatment vignettes and hypoglycemia scenarios.

---

Big Picture: What Insulin Is and Why We Use It

Insulin is a peptide hormone made by pancreatic $\beta$-cells (islets of Langerhans). Its job is to promote the fed/anabolic state by:

• Increasing glucose uptake in muscle and adipose via GLUT4 translocation
• Increasing glycogen synthesis (liver, muscle)
• Increasing lipogenesis and decreasing lipolysis
• Increasing protein synthesis and decreasing proteolysis
• Driving potassium into cells (clinically important!)

USMLE framing: Insulin is the “storage hormone.” When insulin is absent (Type 1) or ineffective (Type 2), the body behaves like it’s starving—even when glucose is high.

First Aid cross-reference: Endocrine → Diabetes mellitus pharmacology; insulin preparations; DKA/HHS.

---

Pathophysiology Refresher (Because Insulin Types Show Up in Context)

Type 1 Diabetes Mellitus (T1DM)

• Autoimmune destruction of $\beta$-cells → absolute insulin deficiency
• Associated with HLA-DR3, HLA-DR4
• Autoantibodies: anti-GAD, anti-islet cell
• Leads to:
  • DKA risk (ketogenesis from uninhibited lipolysis)
  • Weight loss, polyuria, polydipsia

HY Step clue: young patient + weight loss + ketosis + needs insulin.

Type 2 Diabetes Mellitus (T2DM)

• Insulin resistance + eventual $\beta$-cell dysfunction
• Associated with obesity, metabolic syndrome
• Leads to:
  • HHS risk (severe hyperglycemia, dehydration, minimal ketosis)
  • Often initially managed without insulin; insulin later as $\beta$-cells fail

HY Step clue: older/obese + very high glucose + high serum osmolality + no acidosis = HHS.

---

Clinical Presentation & Diagnosis (Fast USMLE Checklist)

Classic symptoms

• Polyuria, polydipsia, polyphagia
• Blurry vision, fatigue
• Recurrent infections (e.g., Candida), poor wound healing (more T2)

Diagnostic criteria (any one, confirmed if asymptomatic)

• A1c $\ge 6.5\%$
• Fasting plasma glucose $\ge 126$ mg/dL
• 2-hour OGTT $\ge 200$ mg/dL
• Random plasma glucose $\ge 200$ mg/dL + symptoms

First Aid cross-reference: Endocrine → Diabetes diagnosis; A1c.

---

Treatment Overview (Where Insulin Types Actually Matter)

When insulin is required/strongly indicated

• All T1DM (lifelong)
• DKA (IV regular insulin)
• HHS (IV insulin after fluids, depending on protocol)
• T2DM with:
  • Marked hyperglycemia (e.g., A1c $\ge 10\%$, glucose $\ge 300$)
  • Symptoms/catabolic state (weight loss)
  • Pregnancy (insulin preferred; some oral agents used selectively)
  • Failure of non-insulin therapy

Step-ready principle: insulin is the most powerful glucose-lowering therapy and the most testable for acute complications.

---

The Core of This Post: Insulin Types You Must Know

Why timing matters

USMLE loves “What insulin caused the 3 AM hypoglycemia?” or “Which insulin covers post-meal spikes?” That’s all about onset, peak, duration.

Insulin types at a glance (high-yield table)

First Aid cross-reference: Endocrine pharm → insulin preparations; onset/peak/duration; mixing rules.

---

High-Yield Memory Anchors (Fast Recall on Test Day)

Rapid vs Regular (classic USMLE compare/contrast)

• Rapid-acting (lispro/aspart/glulisine)

  • Better for postprandial control
  • Can dose immediately before meals
  • Lower risk of “late” post-meal hypoglycemia

• Regular insulin

  • Must be dosed 30 minutes before meals
  • IV option for emergencies (DKA, severe hyperkalemia adjunct)
  • Used in some older sliding-scale regimens (less ideal)

NPH is the “peaky basal”

• Peaks significantly → hypoglycemia risk, especially overnight
• Often used BID (morning + evening)
• “Cloudy” insulin (because it’s a suspension)

Glargine/Detemir/Degludec = basal backbone

• Minimal peak → steadier basal coverage
• Common in basal-bolus therapy with rapid-acting mealtime insulin

---

Mixing Insulins: A Favorite Step 1 Trap

What you can mix

• Regular + NPH: yes
• Rapid-acting + NPH: yes (commonly in practice)

What you should not mix (classic)

• Glargine: do not mix with other insulins
  • It’s formulated to precipitate in subcutaneous tissue; mixing can alter absorption.

Technique pearl: “Clear before cloudy”

When drawing up from vials:

• Draw up clear (Regular/rapid) before cloudy (NPH)
  This prevents contaminating the clear vial with NPH.

First Aid cross-reference: insulin mixing rules; NPH cloudy.

---

Clinical Scenarios (How Insulin Types Show Up in Vignettes)

Scenario 1: “Woke up shaky at 3 AM”

• Patient on evening NPH → nocturnal hypoglycemia due to NPH peak
• Management strategies:
  • Adjust evening NPH dose
  • Add bedtime snack
  • Consider switching basal regimen (e.g., glargine)

HY association: NPH peak = night lows.

Scenario 2: “Meal is delayed after insulin was given”

• Patient took regular insulin 30–45 minutes before food, then meal delayed → hypoglycemia risk
  Rapid-acting would have allowed tighter timing.

Scenario 3: “DKA management in the ED”

• Treat with:
  1. IV fluids
  2. IV regular insulin
  3. Potassium monitoring/repletion
     Insulin drives $K^+$ into cells → can unmask/worsen hypokalemia.

HY warning: If potassium is very low, correct $K^+$ before insulin to avoid arrhythmias.

Scenario 4: Hyperkalemia treatment

• Insulin (often regular IV) + glucose shifts $K^+$ into cells (temporary fix)
• Mechanism: stimulates Na⁺/K⁺-ATPase → intracellular shift

---

Insulin Pharmacology: Mechanism + Adverse Effects (USMLE-Ready)

Mechanism of action

Insulin binds a receptor tyrosine kinase → autophosphorylation → downstream signaling → GLUT4 insertion in adipose/muscle.

First Aid cross-reference: receptor types; RTKs (insulin, IGF-1).

Adverse effects (high yield)

• Hypoglycemia (most important)
  • Symptoms: sweating, tremor, palpitations, anxiety (adrenergic) → confusion, seizures (neuroglycopenic)
• Weight gain
• Lipodystrophy at injection sites (rotate sites)
• Allergic reactions (rare)
• Hypokalemia (insulin shifts $K^+$ into cells)

---

Insulin Regimens You Should Recognize

Basal–bolus (common modern physiology-based regimen)

• Basal: glargine/detemir/degludec (or NPH)
• Bolus: rapid-acting with meals + correction doses

USMLE phrasing: “Tight control with long-acting plus rapid-acting at meals.”

Sliding scale (common in questions, less ideal outpatient)

• Reactive dosing based on glucose readings; can cause swings
• Step 2 may test “it’s not great alone,” but you still must understand it.

---

High-Yield Rapid Review: “Which insulin is it?”

---

First Aid-Style Pearls to Lock In Points

• Insulin receptor = receptor tyrosine kinase (Step 1 classic).
• Regular insulin is IV-usable (DKA, hyperkalemia shift).
• NPH is intermediate + peaks → hypoglycemia.
• Glargine is long-acting + cannot be mixed (common exam line).
• Hypoglycemia is the key toxicity—think autonomic symptoms first, then neuro symptoms.

---

Quick Self-Quiz (Check Your Pattern Recognition)

1. Patient with T1DM has morning headaches and night sweats on NPH: what happened?
2. Which insulin do you start in the ED for DKA?
3. Which insulin is best to cover the glucose spike from dinner?
4. Why can insulin lower potassium?

(If you can answer these quickly, your insulin pharmacology is in great shape.)